Hyperphosphatemia: Hyperphosphatemia is an electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood.
Chronic Kidney Disease
Sandeep Vetteth
https://www.utoledo.edu
Vascular Calcification
Kristina Boström, MD, PhD
https://www.mcdb.ucla.edu/VBTG/VascCalc_Bostrom.ppt
Hem/Onc Emergencies
Peter Newburger, MD, Venee Tubman, MD
https://www.umassmed.edu
The Cellular Environment: Fluids and Electrolytes, Acids and Bases
http://users.ipfw.edu
Dyatrophic Calcinosis
Dr Abdelaziz Elamin, MD, PhD
http://www.pitt.edu/
Functions of the Kidneys
http://www.austincc.edu
Chronic Renal Failure
http://www.hsc.unt.edu
Regulation of Phosphate Transport in Proximal Tubule
Alexander Usorov, MD
http://medicine.med.nyu.edu
Nephrology Grand Rounds
http://medicine.med.nyu.edu
Minerals
Dr Reed Berger
https://www.uic.edu/depts/mcam/nutrition/ppt/Minerals1_add.ppt
Hem/Onc Emergencies
Saulius Girnius
http://www.bumc.bu.edu
Fluid, Electrolyte & Acid-Base Balance
http://academic.evergreen.edu
Polycystic Kidney Disease
http://www.smccd.net
Stressors Affecting
Fluid & Electrolyte Balance
K. Burger, MSEd, MSN, RN, CNE
http://www2.sunysuffolk.edu
Chronic Renal Failure
Matt Crowley, Doug Srygley , Vijay Reddy
https://vmw-lmsc.duhs.duke.edu
Electrolyte Abnormalities in the Hospitalized Patient
Cynthia Seitz MD
http://medicine.nevada.edu
Kidney Function & Disease
McCafferty
http://www.csuchico.edu
200 Latest Published articles of Hyperphosphatemia
1. Hyperphosphatemia in a patient with Candida sepsis.
Dufour, D Robert
Clinical chemistry Volume: 60 Issue: 9 Pages: 1241-2 Published: 2014-Sep
2. Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial.
Takahara, Yuki; Matsuda, Yoshimi; Takahashi, Shunichi; et al.
Clinical nephrology Volume: 82 Issue: 3 Pages: 181-90 Published: 2014-Sep
View Abstract
3. Sucroferric Oxyhydroxide (Velphoro) for Hyperphosphatemia
[Anonymous]
MEDICAL LETTER ON DRUGS AND THERAPEUTICS Volume: 56 Issue: 1449 Pages: 76-77 Published: AUG 18 2014
4. Sucroferric oxyhydroxide (Velphoro) for hyperphosphatemia.
[Anonymous]
The Medical letter on drugs and therapeutics Volume: 56 Issue: 1449 Pages: 76-7 Published: 2014-Aug-18
5. Immobilization-Induced Hyperphosphatemia and Functional Hypoparathyroidism Successfully Treated With Oral Bisphosphonates
Trivedi, Disha D.; Gosmanova, Elvira O.; Wall, Barry M.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES Volume: 348 Issue: 2 Pages: 179-180 Published: AUG 2014
6. Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis
Karavetian, Mirey; de Vries, Nanne; Rizk, Rana; et al.
NUTRITION REVIEWS Volume: 72 Issue: 7 Pages: 471-482 Published: JUL 2014
from Publisher View Abstract
7. Severe Nonuremic Calciphylaxis Due to Hyperphosphatemia Resolving With Multimodality Treatment Including Phosphate Binders
Wanat, Karolyn A.; Stewart, Campbell L.; Negoianu, Dan; et al.
JAMA DERMATOLOGY Volume: 150 Issue: 6 Pages: 671-673 Published: JUN 2014
8. Treatment of Hyperphosphatemia With Bixalomer in Japanese Patients on Long-Term Hemodialysis With Gastrointestinal Symptoms
Ito, Kae; Takeshima, Akiko; Shishido, Kanji; et al.
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 18 Special Issue: SI Supplement: 2 Pages: 19-23 Published: JUN 2014
from Publisher View Abstract
9. Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study
Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; et al.
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 18 Special Issue: SI Supplement: 2 Pages: 24-32 Published: JUN 2014
from Publisher View Abstract
10. A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS)
Abbasi, Farzaneh; Ghafouri-Fard, Soudeh; Javaheri, Mona; et al.
GENE Volume: 542 Issue: 2 Pages: 269-271 Published: JUN 1 2014
from Publisher View Abstract
11. What Can We Learn from the Saga of Chitosan Gums in Hyperphosphatemia Therapy?
Oh, Man S.; Uribarri, Jaime
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 9 Issue: 5 Pages: 967-970 Published: MAY 7 2014
from Publisher View Abstract
12. LENGTH OF STAY AND MORTALITY IN HYPERPHOSPHATEMIA PATIENTS ADMINISTERED PHOSPHATE BINDERS COMPARED WITH MATCHED CONTROLS
Belk, K. W.; Craver, C. W.
VALUE IN HEALTH Volume: 17 Issue: 3 Pages: A291-A291 Meeting Abstract: PUK7 Published: MAY 2014
13. SYSTEMATIC REVIEW AND META-ANALYSIS OF SEVELAMER VERSUS CALCIUM-BASED BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE
Patel, Leena; Bernard, Lisa M.; Elder, Grahame J.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 29 Supplement: 3 Pages: 148-148 Meeting Abstract: SP231 Published: MAY 2014
14. LANTHANUM CARBONATE FOR HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE BEFORE AND DURING DIALYSIS: ACOST-EFFECTIVENESS ANALYSIS IN SPAIN
Gros, Blanca; Galan, Antonio; Gonzalez-Parra, Emilio; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 29 Supplement: 3 Pages: 270-271 Meeting Abstract: SP595 Published: MAY 2014
15. HYPERPHOSPHATEMIA IS A RISK FACTOR OF ACCELERATED DECLINE IN RENAL FUNCTION IN CAPD PATIENTS
Kuo Li-Chueh; Hwang Jyh-Chang; Cheng Ben-Chung; et al.
NEPHROLOGY Volume: 19 Special Issue: SI Supplement: 2 Pages: 151-151 Published: MAY 2014
16. ISOLATED PARAPROTEINEMIA CAUSING SPURIOUS HYPERPHOSPHATEMIA
Aggarwal, Aakash; Bhardwaj, Rahul
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 63 Issue: 5 Pages: A21-A21 Meeting Abstract: 12 Published: MAY 2014
17. HYPERPHOSPHATEMIA WITH HIGH FIBROBLAST GROWTH FACTOR 23: A COMPLEX GENETIC DISORDER
Raina, R.; Hanley, P.; Lou, Linda; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 63 Issue: 5 Pages: A93-A93 Meeting Abstract: 298 Published: MAY 2014
18. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles
Locatelli, Francesco; Del Vecchio, Lucia; Violo, Leano; et al.
EXPERT OPINION ON DRUG SAFETY Volume: 13 Issue: 5 Pages: 551-561 Published: MAY 2014
from Publisher View Abstract
19. Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis
Miao, Li-Ying; Zhu, Bin; He, Xiao-Zhou; et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE Volume: 7 Issue: 4 Pages: 947-952 Published: APR 2014
from Publisher View Abstract
20. Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia
Akizawa, Tadao; Origasa, Hideki; Kameoka, Chisato; et al.
Group Author(s): Bixalomer Study Grp
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 18 Issue: 2 Pages: 122-131 Published: APR 2014
from Publisher View Abstract
21. Spurious hyperphosphatemia in a case of multiple myeloma.
Chakraborty, Sutirtha; Sen, Susruta; Gupta, Debkishore; et al.
Indian journal of clinical biochemistry : IJCB Volume: 29 Issue: 2 Pages: 250-2 Published: 2014-Apr (Epub 2013 Aug 08)
from Publisher View Abstract
22. Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
Yokoyama, Keitaro; Hirakata, Hideki; Akiba, Takashi; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 9 Issue: 3 Pages: 543-552 Published: MAR 7 2014
from Publisher View Abstract
23. Dietary Trends and Management of Hyperphosphatemia Among Patients With Chronic Kidney Disease: An International Survey of Renal Care Professionals
Fouque, Denis; Cruz Casal, Maria; Lindley, Elizabeth; et al.
JOURNAL OF RENAL NUTRITION Volume: 24 Issue: 2 Pages: 110-115 Published: MAR 2014
from Publisher View Abstract
24. Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats
Yamazaki-Nakazawa, Ai; Mizobuchi, Masahide; Ogata, Hiroaki; et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY Volume: 18 Issue: 1 Pages: 56-64 Published: FEB 2014
from Publisher View Abstract
25. Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis - a systematic review and meta-analysis of randomized controlled trials
Huang, Wenhui; Liu, Jing; Tang, Yu; et al.
CURRENT MEDICAL RESEARCH AND OPINION Volume: 30 Issue: 1 Pages: 99-108 Published: JAN 2014
from Publisher View Abstract
26. Hyperphosphatemia and phosphate binders: effectiveness and safety
Kalaitzidis, Rigas G.; Elisaf, Moses S.
CURRENT MEDICAL RESEARCH AND OPINION Volume: 30 Issue: 1 Pages: 109-112 Published: JAN 2014
from Publisher View Abstract
27. The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia
Jiang, Jie-Long; Ren, Wei; Li, Yan; et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY Volume: 45 Issue: 6 Pages: 1725-1731 Published: DEC 2013
from Publisher View Abstract
28. Long-Term Treatment of Hyperphosphatemia With Bixalomer in Japanese Hemodialysis Patients
Akizawa, Tadao; Kameoka, Chisato; Kaneko, Yuichiro; et al.
Group Author(s): Bixalomer Study Grp
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 17 Issue: 6 Pages: 612-619 Published: DEC 2013
from Publisher View Abstract
29. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
Streja, Elani; Lau, Wei Ling; Goldstein, Leanne; et al.
KIDNEY INTERNATIONAL SUPPLEMENTS Volume: 3 Issue: 5 Pages: 462-468 Published: DEC 2013
from Publisher View Abstract
30. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia
Shende, Pravin; Deshmukh, Kiran; Trotta, Fransesco; et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS Volume: 456 Issue: 1 Pages: 95-100 Published: NOV 1 2013
from Publisher View Abstract
31. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema
Gracia-Iguacel, Carolina; Gonzalez-Parra, Emilio; Rodriguez-Osorio, Laura; et al.
JOURNAL OF BONE AND MINERAL METABOLISM Volume: 31 Issue: 6 Pages: 703-707 Published: NOV 2013
from Publisher View Abstract
32. Use of nicotinamide to treat hyperphosphatemia in dialysis patients.
Lenglet, Aurelie; Liabeuf, Sophie; Guffroy, Pauline; et al.
Drugs in R&D Volume: 13 Issue: 3 Pages: 165-73 Published: 2013-Sep
from Publisher View Abstract
33. Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients
Ye, Zhong; Palazzo, Juan P.; Lin, Liz; et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Volume: 28 Issue: 9 Pages: 1469-1475 Published: SEP 2013
from Publisher View Abstract
34. MANAGEMENT OF HYPERPHOSPHATEMIA IN HAEMODIALYSIS PATIENTS IN AN OUTER METROPOLITAN DIALYSIS UNIT: THE OPERATION PHOSPHATE AGGRESSIVE LOWERING (OPAL) PROJECT
Light, C.; Pikoos, A.; Kulkarni, H.
NEPHROLOGY Volume: 18 Special Issue: SI Supplement: 1 Pages: 63-64 Meeting Abstract: 192 Published: SEP 2013
35. Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010
Wojcicki, Janet M.
BMC NEPHROLOGY Volume: 14 Article Number: 178 Published: AUG 21 2013
from Publisher View Abstract
36. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
Covic, Adrian; Rastogi, Anjay
BMC NEPHROLOGY Volume: 14 Article Number: 153 Published: JUL 18 2013
from Publisher View Abstract
37. Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate
Arikan, Hakki; Guler, Derya; Birdal, Gurdal; et al.
RENAL FAILURE Volume: 35 Issue: 6 Pages: 875-878 Published: 2013
from Publisher View Abstract
38. Nicotinic Acid and Nicotinamide: A Review of Their Use for Hyperphosphatemia in Dialysis Patients
Rennick, Amanda; Kalakeche, Rabih; Seel, Lindsey; et al.
PHARMACOTHERAPY Volume: 33 Issue: 6 Pages: 683-690 Published: JUN 2013
from Publisher View Abstract
39. Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review
Latif, Faisal; Khalid, Muhammad Masood; Khan, Fahad; et al.
JOURNAL OF CARDIOVASCULAR MEDICINE Volume: 14 Issue: 6 Pages: 410-415 Published: JUN 2013
from Publisher View Abstract
40. [Pharmacological and clinical profile of bixalomer (Kiklin() capsules): a new therapeutic agent for hyperphosphatemia].
Taniguchi, Keiichi; Kakuta, Hirotoshi; Tomura, Yuichi; et al.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica Volume: 141 Issue: 6 Pages: 333-7 Published: 2013-Jun
41. Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients
Gao, Zhuo; Lun, Li-De; Li, Xin-Lun
EXPERIMENTAL AND THERAPEUTIC MEDICINE Volume: 5 Issue: 6 Pages: 1732-1736 Published: JUN 2013
from Publisher View Abstract
42. Pharmacological and clinical profile of bixalomer (Kiklin (R) capsules): a new therapeutic agent for hyperphosphatemia
Taniguchi, Keiichi; Kakuta, Hirotoshi; Tomura, Yuichi; et al.
Folia Pharmacologica Japonica Volume: 141 Issue: 6 Pages: 333-337 Published: JUN 2013
43. LANTHANUM CARBONATE FOR HYPERPHOSPHATEMIA IN PATIENTS ON PERITONEAL DIALYSIS
Ohno, Michiya; Ohashi, Hiroshige; Oda, Hiroshi; et al.
PERITONEAL DIALYSIS INTERNATIONAL Volume: 33 Issue: 3 Pages: 297-303 Published: MAY-JUN 2013
from Publisher View Abstract
44. Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial
Dwyer, Jamie P.; Sika, Mohammed; Schulman, Gerald; et al.
Group Author(s): Collaborative Study Grp
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 61 Issue: 5 Pages: 759-766 Published: MAY 2013
from Publisher View Abstract
45. HYPERPHOSPHATEMIA INDUCES INTEGRIN LINKED KINASE EXPRESSION AND LEADS TO CELLULAR SENESCENCE AND AGING: STUDIES IN VIVO AND IN VITRO
Troyano Suarez, Nuria; Del Nogal Avila, Maria; Mora Valenciano, Ines; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 28 Supplement: 1 Pages: 60-60 Published: MAY 2013
46. HYPERPHOSPHATEMIA AS AN INDICATOR FOR INITIATING RENAL REPLACEMENT THERAPY
Lu, Yueh-An; Liu, Yen-Chun; Lee, Shen-Yang; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 28 Supplement: 1 Pages: 156-157 Published: MAY 2013
47. LOW DOSE NICOTINAMIDE AS AN ADJUNCTIVE THERAPY TO CALCIUM CARBONATE FOR CONTROL OF HYPERPHOSPHATEMIA IN HEMODIALYSIS PATIENTS
ElSharkawy, Magdy M. S.; Kamel, Mostafa; Elhamamsy, Manal; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 28 Supplement: 1 Pages: 253-253 Published: MAY 2013
48. DOSE RELATIVITY OF SEVELAMER HYDROCHLORIDE AND LANTHANUM CARBONATE UNDER REAL-WORLD CONDITIONS: IMPLICATIONS FOR MANAGEMENT OF PATIENTS WITH END-STAGE RENAL DISEASE AND HYPERPHOSPHATEMIA
Copley, J. B.; Wilson, R. J.; Keith, M. S.
VALUE IN HEALTH Volume: 16 Issue: 3 Pages: A192-A192 Published: MAY 2013
49. Does Hyperphosphatemia induce Monocyte Dysfunction in People with chronic Kidney Failure?
Luthe, A.; Zawada, A.; Seiler, S.; et al.
INTERNIST Volume: 54 Supplement: 1 Pages: 47-48 Published: APR 2013
50. PSUEDO HYPERPHOSPHATEMIA IN MULTIPLE MYELOMA
Kumar, Anshul; Dhakarwal, Pradeep; Agrawal, Vibha; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 61 Issue: 4 Pages: A57-A57 Meeting Abstract: 166 Published: APR 2013
51. [Recognition for treating chronic renal failure hyperphosphatemia by Chinese medicine and pharmacy].
Bi, Li-ming; Gao, Jun; Zhu, Dong-yun
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban Volume: 33 Issue: 3 Pages: 425-7, 431 Published: 2013-Mar
52. Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
Hutchison, Alastair J.; Gill, Maggie; Copley, J. Brian; et al.
BMC NEPHROLOGY Volume: 14 Article Number: 40 Published: FEB 18 2013
from Publisher View Abstract
53. Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China
Xu, Jing; Zhang, Yi-Xiang; Yu, Xue-Qing; et al.
BMC NEPHROLOGY Volume: 14 Article Number: 29 Published: FEB 4 2013
from Publisher View Abstract
54. Adherence to Phosphate Binder Therapy Is the Primary Determinant of Hyperphosphatemia Incidence in Patients Receiving Peritoneal Dialysis
Hung, Kai-Yin; Liao, Shang-Chih; Chen, Tzu-Hsiu; et al.
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 17 Issue: 1 Pages: 72-77 Published: FEB 2013
from Publisher View Abstract
55. Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study
Yap, Yit-Sheung; Chi, Wen-Che; Lin, Cheng-Hao; et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY Volume: 45 Issue: 1 Pages: 163-172 Published: FEB 2013
from Publisher View Abstract
56. A Physiologic-Based Approach to the Evaluation of a Patient With Hyperphosphatemia
Leaf, David E.; Wolf, Myles
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 61 Issue: 2 Pages: 330-336 Published: FEB 2013
from Publisher View Abstract
57. Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model
Yamauchi, Haruo; Motomura, Noboru; Chung, Ung-il; et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Volume: 145 Issue: 2 Pages: 522-530 Published: FEB 2013
from Publisher View Abstract
58. Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence
Jesus Lloret, Ma; Ruiz-Garcia, Cesar; DaSilva, Iara; et al.
PATIENT PREFERENCE AND ADHERENCE Volume: 7 Pages: 1147-1156 Published: 2013
from Publisher View Abstract
59. Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom.
Thompson, Melissa; Bartko-Winters, Susan; Bernard, Lisa; et al.
Journal of medical economics Volume: 16 Issue: 6 Pages: 744-55 Published: 2013 (Epub 2013 Apr 17)
from Publisher View Abstract
60. Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis - system review of lanthanum carbonate
Guo, Hua; Zhang, Xiaojuan; Tang, Shaowen; et al.
RENAL FAILURE Volume: 35 Issue: 10 Pages: 1455-1464 Published: 2013
from Publisher View Abstract
61. A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom.
Bernard, Lisa; Mendelssohn, David; Dunn, Elizabeth; et al.
Journal of medical economics Volume: 16 Issue: 1 Pages: 1-9 Published: 2013 (Epub 2012 Sep 10)
from Publisher View Abstract
62. Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia
He, Anqi; Zhou, Fengshan; Ye, Fang; et al.
JOURNAL OF SPECTROSCOPY Article Number: UNSP 593636 Published: 2013
from Publisher View Abstract
63. Should hyperphosphatemia be treated in 2012? And how?
Hummel, A.; Frantzen, L.; Jaubert, D.
NEPHROLOGIE & THERAPEUTIQUE Volume: 8 Special Issue: 2 Pages: 5-9 Published: DEC 2012
64. Spurious Hyperphosphatemia: A Case for Caution
Aiyer, Ravi; Kazory, Amir
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 60 Issue: 6 Pages: 1050-1051 Published: DEC 2012
65. Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD
Schiavi, Susan C.; Tang, Wen; Bracken, Christina; et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 23 Issue: 10 Pages: 1691-1700 Published: OCT 2012
from Publisher View Abstract
66. [Hyperphosphatemia and cardiovascular diseases : impact of vascular calcification and endothelial dysfunction].
Iijima, Katsuya
Clinical calcium Volume: 22 Issue: 10 Pages: 1505-13 Published: 2012-Oct
View Abstract
67. Highly Selective and Low-swelling Phosphate-binding Polymer for Hyperphosphatemia Therapy
Inoue, Atsushi; Minakami, Satoshi; Kanno, Takami; et al.
CHEMISTRY LETTERS Volume: 41 Issue: 9 Pages: 932-933 Published: SEP 5 2012
from Publisher View Abstract
68. Calcium carbonate compositions for preventing or treating hyperphosphatemia
Patent Number: US 08257750
Patent Assignee: Kibow Biotech Inc
Inventor(s): Ranganathan, Natarajan.
Official Gazette of the United States Patent and Trademark Office Patents Published: SEP 4 2012
View Abstract
69. Hyperphosphatemia in a Patient with Respiratory Problems
Toutkaboni, Mihan Pourabdollah; Taheri, Zohreh Mohammad; Mohammadi, Forouzan; et al.
LABMEDICINE Volume: 43 Issue: 6 Pages: 291-293 Published: FAL 2012
from Publisher View Abstract
70. L'iperfosforemia nell'insufficienza renale cronica di grado moderato: un paradosso della nefrologia moderna.
[Hyperphosphatemia in moderate CKD: a paradox of modern nephrology].
Bellasi, Antonio
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia Volume: 29 Issue: 5 Pages: 519 Published: 2012 Sep-Oct
71. Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature
Ladenhauf, Hannah N.; Stundner, Ottokar; Spreitzhofer, Florian; et al.
PEDIATRIC SURGERY INTERNATIONAL Volume: 28 Issue: 8 Pages: 805-814 Published: AUG 2012
from Publisher View Abstract
72. Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients: A Canadian Payer Perspective
Vegter, Stefan; Tolley, Keith; Keith, Michael S.; et al.
CLINICAL THERAPEUTICS Volume: 34 Issue: 7 Pages: 1531-1543 Published: JUL 2012
from Publisher View Abstract
73. HYPERPHOSPHATEMIA - THE RISK FACTOR FOR ADVERSE OUTCOME IN MAINTENANCE HEMODIALYSIS PATIENTS
Petrovic, Dejan; Obrenovic, Radmila; Trbojevic-Stankovic, Jasna; et al.
JOURNAL OF MEDICAL BIOCHEMISTRY Volume: 31 Issue: 3 Pages: 239-245 Published: JUL-SEP 2012
from Publisher View Abstract
74. Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphatemia
Lou, L. M.; Caverni, A.; Gimeno, J. A.; et al.
Group Author(s): Aragon CKD Res Grp
CLINICAL NEPHROLOGY Volume: 77 Issue: 6 Pages: 476-483 Published: JUN 2012
from Publisher View Abstract
75. A MANAGED CARE COST-OFFSET MODEL FOR FERRIC CITRATE, AN EXPERIMENTAL PHOSPHATE BINDER THAT CAN REDUCE THE USE OF ERYTHROPOIESIS-STIMULATING AGENTS AND INTRAVENOUS IRON IN HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA
Mutell, R.; Rubin, J. L.; Bond, T. C.; et al.
VALUE IN HEALTH Volume: 15 Issue: 4 Pages: A155-A155 Published: JUN 2012
76. RELATIONSHIP OF KT/VM AND PROTEIN CATABOLIC RATE WITH HYPERPHOSPHATEMIA IN PATIENTS UNDER CHRONIC HEMODIALYSIS
Marka-Castro, Edwin; Torres Zamora, Manuel Ignacio; Giron-Mino, Juan; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 27 Supplement: 2 Pages: 198-198 Published: MAY 2012
77. PILL BURDEN AND ITS ASSOCIATION WITH MEDICATION POSSESSION RATIO AMONG HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA
Bond, Christopher; Wang, Steven; Alfieri, Thomas; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 27 Supplement: 2 Pages: 280-280 Published: MAY 2012
78. HYPERPHOSPHATEMIA DIRECTLY AFFECTS ENDOTHELIAL FUNCTION BY DOWN-REGULATING ANNEXIN II
Marco, Giovanna Seno D. I.; Koenig, Maximilian; Stock, Christian; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 27 Supplement: 2 Pages: 441-441 Published: MAY 2012
79. A META-ANALYSIS OF FERRIC CITRATE FOR HYPERPHOSPHATEMIA: THE EFFECTS OF AN ORAL IRON-CONTAINING PHOSPHATE BINDER ON SERUM FERRITIN AND SATURATED TRANSFERRIN IN HEMODIALYSIS PATIENTS
Bond, Christopher; Jensen, Donna; Wang, Steven; et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 27 Supplement: 2 Pages: 490-490 Published: MAY 2012
80. Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells
Takei, Yuichiro; Yamamoto, Hironori; Sato, Tadatoshi; et al.
BONE Volume: 50 Issue: 4 Pages: 998-1005 Published: APR 2012
from Publisher View Abstract
81. Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study)
Shigematsu, Takashi; Negi, Shigeo
Group Author(s): COLC Res Grp
NEPHROLOGY DIALYSIS TRANSPLANTATION Volume: 27 Issue: 3 Pages: 1050-1054 Published: MAR 2012
from Publisher View Abstract
82. The effects of applying the transtheoretical model for behavioural correction in hyperphosphatemia
Chen, Y. H.; Peng, H. L.; Chen, Y. L.
INTERNATIONAL JOURNAL OF NURSING PRACTICE Volume: 18 Special Issue: SI Supplement: 1 Pages: 143-144 Published: FEB 2012
83. Effect of Oral JTT-751 (Ferric Citrate) on Hyperphosphatemia in Hemodialysis Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Yokoyama, Keitaro; Hirakata, Hideki; Akiba, Takashi; et al.
AMERICAN JOURNAL OF NEPHROLOGY Volume: 36 Issue: 5 Pages: 478-487 Published: 2012
from Publisher View Abstract
84. Effects of Phosphonoformic Acid and Renagel on Renal Type IIa Sodium-Dependent Phosphate Cotransporter mRNA Expression in Hyperphosphatemia Rats
Zeng, Ming; Wang, Xiaoyun; Wang, Xiaobing; et al.
RENAL FAILURE Volume: 34 Issue: 3 Pages: 358-363 Published: 2012
from Publisher View Abstract
85. Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hypophosphatemia at the time of blast crisis of Phneg CML to acute myelomoncytic leukemia.
Salomon, Ophira; Holtzman, Eli J; Beckerman, Pazit; et al.
Experimental hematology & oncology Volume: 1 Issue: 1 Pages: 24 Published: 2012 Aug 29
from Publisher View Abstract
86. The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients.
Shigematsu, Takashi; Nakashima, Yuri; Ohya, Masaki; et al.
International journal of nephrology and renovascular disease Volume: 5 Pages: 81-9 Published: 2012 (Epub 2012 May 29)
from Publisher View Abstract
87. Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective
Park, Haesuk; Rascati, Karen L.; Keith, Michael S.; et al.
VALUE IN HEALTH Volume: 14 Issue: 8 Pages: 1002-1009 Published: DEC 2011
from Publisher View Abstract
88. Hyperphosphatemia and Hypozincemia Aggravated Hypertension and Cardiac Dysfunction in SHR/NDmcr-cp, a Model of Metabolic Syndrome
Suzuki, Yuka; Yamaguchi, Takanori; Kato, Ai; et al.
CIRCULATION Volume: 124 Issue: 21 Supplement: S Meeting Abstract: A16743 Published: NOV 22 2011
View Abstract
89. Hyperphosphatemia Causes Endothelial Dysfunction by Inhibiting Akt-Endothelial Nitric Oxide Synthase Pathway in Chronic Kidney Disease Rats
Taketani, Yutaka; Van, Tan Vu; Watari, Eriko; et al.
CIRCULATION Volume: 124 Issue: 21 Supplement: S Meeting Abstract: A10044 Published: NOV 22 2011
View Abstract
90. Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis.
Vasantha, J; Soundararajan, P; Vanitharani, N; et al.
Indian journal of nephrology Volume: 21 Issue: 4 Pages: 245-9 Published: 2011-Oct
from Publisher View Abstract
91. Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
Vegter, Stefan; Tolley, Keith; Keith, Michael S.; et al.
VALUE IN HEALTH Volume: 14 Issue: 6 Pages: 852-858 Published: SEP-OCT 2011
from Publisher View Abstract
92. The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover study
Kilpatrick, Ryan D.; Danese, Mark D.; Belozeroff, Vasily; et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Volume: 20 Issue: 9 Pages: 914-921 Published: SEP 2011
from Publisher View Abstract
93. HYPOPHOSPHATEMIA AND HYPERPHOSPHATEMIA ASSOCIATED WITH INCREASED MORTALITY IN INCIDENT AUSTRALIAN AND NEW ZEALAND DIALYSIS PATIENTS
Toussaint, N. D.; Mcdonald, S. P.; Walker, R. G.; et al.
NEPHROLOGY Volume: 16 Supplement: 1 Pages: 26-27 Meeting Abstract: 011 Published: SEP 2011
94. Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells
Takemura, Aya; Iijima, Katsuya; Ota, Hidetaka; et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Volume: 31 Issue: 9 Pages: 2054-U370 Published: SEP 2011
from Publisher View Abstract
95. Alteplase as hemodialysis catheter locking solution and spurious hyperphosphatemia
Sombolos, Kostas; Bamichas, Gerasimos; Hatsiou, Victoria; et al.
JOURNAL OF VASCULAR ACCESS Volume: 12 Issue: 3 Pages: 269-269 Published: JUL-SEP 2011
96. Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparations
Deepak, Parakkal; Ehrenpreis, Eli D.
WORLD JOURNAL OF GASTROENTEROLOGY Volume: 17 Issue: 21 Pages: 2681-2682 Published: JUN 7 2011
97. Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparations
Deepak, Parakkal; Ehrenpreis, Eli D.
WORLD JOURNAL OF GASTROENTEROLOGY Volume: 17 Issue: 21 Pages: 2681-2681 Published: JUN 7 2011
from Publisher View Abstract
98. Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparations.
Deepak, Parakkal; Ehrenpreis, Eli D
World journal of gastroenterology : WJG Volume: 17 Issue: 21 Pages: 2681-2 Published: 2011-Jun-7
from Publisher View Abstract
99. A Case of Severe Hyperphosphatemia and Hypocalcemia Caused by Bowel Preparation for Colonoscopy using Small Amounts of Oral Sodium Phosphate in End-stage Renal Disease
Park, Ji Hoon; Lee, Sang Wook; Kim, Young Jae; et al.
Chung-Ang Journal of Medicine Volume: 36 Issue: 1-2 Pages: 29-33 Published: JUN 2011
View Abstract
100. Controle da hiperfosfatemia na DRC
Management of hyperphosphatemia in CKD
Carvalho, Aluizio Barbosa de; Cuppari, Lilian
Jornal Brasileiro de Nefrologia Volume: 33 Issue: 2 Pages: 189-247 Published: 2011-06
101. THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE
Vegter, S.; Tolley, K.; Levin, A.; et al.
VALUE IN HEALTH Volume: 14 Issue: 3 Pages: A77-A77 Published: MAY 2011
102. LANTHANUM CARBONATE (LC) VS SEVELAMER FOR TREATING HYPERPHOSPHATEMIA IN CKD
Copley, J. Brian; Pratt, Raymond; Martin, Patrick; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 57 Issue: 4 Pages: A33-A33 Meeting Abstract: 68 Published: APR 2011
103. Effect of Lanthanum Carbonate Treatment on Bone in Japanese Dialysis Patients With Hyperphosphatemia
Shigematsu, Takashi; Tokumoto, Akihide; Nakaoka, Akihisa; et al.
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 15 Issue: 2 Pages: 176-184 Published: APR 2011
from Publisher View Abstract
104. Controle da hiperfosfatemia na DRC.
[Management of hyperphosphatemia in CKD].
de Carvalho, Aluizio Barbosa; Cuppari, Lilian
Corporate Author(s): Sociedade Brasileira de Nefrologia
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia Volume: 33 Suppl 1 Pages: 1-6 Published: 2011-Apr
105. Controle da hiperfosfatemia na DRC.
[Management of hyperphosphatemia in CKD].
de Carvalho, Aluizio Barbosa; Cuppari, Lilian
Corporate Author(s): Sociedade Brasileira de Nefrologia
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia Volume: 33 Issue: 2 Pages: 191-6 Published: 2011 Apr-Jun
106. Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.
Knoderer, Chad A; Knoderer, Holly M
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG Volume: 16 Issue: 2 Pages: 87-91 Published: 2011-Apr
from Publisher View Abstract
107. Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia
Falcini, F.; Masi, L.; Cavalli, L.; et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Volume: 29 Issue: 2 Pages: 379-380 Published: MAR-APR 2011
108. Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure
Ivanov, M.; Mihailovic-Stanojevic, N.; Milanovic, J. Grujic; et al.
ACTA PHYSIOLOGICA HUNGARICA Volume: 98 Issue: 1 Pages: 1-7 Published: MAR 2011
from Publisher View Abstract
109. Physicochemical Characterization of La-2(CO3)(3)center dot 4H(3)O, a New and Promising Agent for the Treatment of Hyperphosphatemia
Baran, Enrique J.
LATIN AMERICAN JOURNAL OF PHARMACY Volume: 30 Issue: 1 Pages: 126-131 Published: FEB 2011
View Abstract
110. Prevention and Control of Phosphate Retention/Hyperphosphatemia in CKD-MBD: What Is Normal, When to Start, and How to Treat?
Martin, Kevin J.; Gonzalez, Esther A.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 6 Issue: 2 Pages: 440-446 Published: FEB 2011
from Publisher View Abstract
111. A 90-Year-Old Man With Hyperphosphatemia
Lovekar, Shachi; Chen, Joline L. T.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 57 Issue: 2 Pages: 342-346 Published: FEB 2011
from Publisher View Abstract
112. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro
Sage, Andrew P.; Lu, Jinxiu; Tintut, Yin; et al.
KIDNEY INTERNATIONAL Volume: 79 Issue: 4 Pages: 414-422 Published: FEB 2011
from Publisher View Abstract
113. Effect of Short-Term Low-Protein Diet Supplemented with Keto Acids on Hyperphosphatemia in Maintenance Hemodialysis Patients
Li, Haiming; Long, Quan; Shao, Chunhai; et al.
BLOOD PURIFICATION Volume: 31 Issue: 1-3 Pages: 33-40 Published: 2011
from Publisher View Abstract
114. New-onset headache in an elderly man with uremia that improved only after correction of hyperphosphatemia ("uremic headache"): a case report.
Razdan, Sushil; Pandita, Kk; Chopra, Vanilla; et al.
Journal of medical case reports Volume: 5 Pages: 77 Published: 2011 Feb 24
from Publisher View Abstract
115. Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder
Calo, Lorenzo A.; Savica, Vincenzo; Piccoli, Antonio; et al.
RENAL FAILURE Volume: 33 Issue: 1 Pages: 11-14 Published: 2011
from Publisher View Abstract
116. How KDIGO Will (or Will Not) Influence the Management of Hyperphosphatemia
Kovesdy, Csaba P.
SEMINARS IN DIALYSIS Volume: 24 Issue: 1 Pages: 35-36 Published: JAN-FEB 2011
117. Erroneous determination of hyperphosphatemia ('pseudohyperphosphatemia') in sera of patients that have been treated with liposomal amphotericin B (AmBisome)
Jensen, Gerard M.; Bunch, Tarquinus H.; Wolf, Steven; et al.
CLINICA CHIMICA ACTA Volume: 411 Issue: 23-24 Pages: 1900-1905 Published: DEC 14 2010
from Publisher View Abstract
118. Phosphoproteomic Analysis in the Endothelial Cells Damaged by Hyperphosphatemia
Kitamura, Tomoyo; Taketani, Yutaka; Watari, Eriko; et al.
CIRCULATION Volume: 122 Issue: 21 Supplement: S Meeting Abstract: A18953 Published: NOV 23 2010
View Abstract
119. Extended Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia
Bostom, Andrew G.; MacLean, Alexandra A.; Maccubbin, Darbie; et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Volume: 30 Issue: 11 Pages: E200-E200 Published: NOV 2010
120. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi, Masahiro; Fukagawa, Masafumi
Clinical calcium Volume: 20 Issue: 11 Pages: 1700-8 Published: 2010-Nov
from Publisher View Abstract
121. Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III-V)
Biggar, Patrick; Ketteler, Markus
EXPERT OPINION ON PHARMACOTHERAPY Volume: 11 Issue: 16 Pages: 2739-2750 Published: NOV 2010
from Publisher View Abstract
122. Terapia dell'iperfosforemia nei pazienti in trattamento dialitico: ruolo dei chelanti del fosforo.
[Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
Malberti, Fabio
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia Volume: 27 Suppl 52 Pages: S47-54 Published: 2010 Nov-Dec
View Abstract
123. EFFICACY OF PHOSPHATE BINDER SEVELAMER IN CHILDREN WITH HYPERPHOSPHATEMIA DUE TO TUMOR LYSIS SYNDROME
Kahlon, Dilraj; Dinand, Veronique; Bhat, Sunil; et al.
PEDIATRIC BLOOD & CANCER Volume: 55 Issue: 5 Pages: 953-953 Published: NOV 2010
124. Increased extraosseus 99m-technetium hydroxy diphosphonate uptake in chronic kidney disease patients with secondary hyperparathyroidism. Correlation with hyperphosphatemia
Enevoldsen, L. H.; Heaf, J.; Hasbak, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING Volume: 37 Supplement: 2 Pages: S471-S471 Published: OCT 2010
125. Flow-through peritoneal dialysis in neonatal enema-induced hyperphosphatemia
Kostic, Dusan; Dutra Rodrigues, Andre Broggin; Leal, Antonio; et al.
PEDIATRIC NEPHROLOGY Volume: 25 Issue: 10 Pages: 2183-2186 Published: OCT 2010
from Publisher View Abstract
126. Self-Adjustment of Phosphate Binder Dose to Meal Phosphorus Content Improves Management of Hyperphosphatemia in Children with Chronic Kidney Disease (CKD)
Ahlenstiel, T.; Pape, L.; Ehrich, J. H. H.; et al.
PEDIATRIC NEPHROLOGY Volume: 25 Issue: 9 Pages: 1906-1906 Meeting Abstract: 555 Published: SEP 2010
127. Enema-Induced Hyperphosphatemia in a Newborn - Clinical Experience with Flow-Through Peritoneal Dialysis
Koch, V.; Kostic, D.; Metran, C.
PEDIATRIC NEPHROLOGY Volume: 25 Issue: 9 Pages: 1941-1941 Meeting Abstract: 734 Published: SEP 2010
128. PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease
Geisser, P.; Philipp, E.
CLINICAL NEPHROLOGY Volume: 74 Issue: 1 Pages: 4-11 Published: JUL 2010
View Abstract
129. Hyperphosphatemia: understanding the role of phosphate metabolism.
Podd, Daniel
JAAPA : official journal of the American Academy of Physician Assistants Volume: 23 Issue: 7 Pages: 32-7 Published: 2010-Jul
130. Overexpression of parathyroid pituitary-specific transcription factor (Pit)-1 in hyperphosphatemia-induced hyperparathyroidism of chronic renal failure rats
Jiang Ying; Wang Mei
CHINESE MEDICAL JOURNAL Volume: 123 Issue: 12 Pages: 1566-1570 Published: JUN 20 2010
from Publisher View Abstract
131. Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain
Loh, Tze Ping; Saw, Sharon; Sethi, Sunil Kumar
CLINICAL CHEMISTRY Volume: 56 Issue: 6 Pages: 892-895 Published: JUN 2010
132. Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain Commentary
Roy, Vivek
CLINICAL CHEMISTRY Volume: 56 Issue: 6 Pages: 895-896 Published: JUN 2010
133. Hyperphosphatemia in a 56-Year-Old Man with Hypochondrial Pain Commentary
Endres, David B.
CLINICAL CHEMISTRY Volume: 56 Issue: 6 Pages: 896-896 Published: JUN 2010
134. Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia.
Nerbass, Fabiana B; Morais, Jyana G; dos Santos, Rafaela G; et al.
Jornal brasileiro de nefrologia : ʹorgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia Volume: 32 Issue: 2 Pages: 149-55 Published: 2010 Apr-Jun
from Publisher View Abstract
135. HYPERPHOSPHATEMIA IN CHILDREN RECEIVING LIPOSOMAL AMPHOTERICIN B
Knoderer, Holly; Ricci, Michelle; Knoderer, Chad
PEDIATRIC BLOOD & CANCER Volume: 54 Issue: 6 Pages: 821-821 Published: JUN 2010
136. Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials
Ahmed, Mohamed H.
RENAL FAILURE Volume: 32 Issue: 5 Pages: 642-646 Published: 2010
from Publisher View Abstract
137. HYPERPHOSPHATEMIA
Orrego, John J.; Sheehan, Michael
ENDOCRINE PRACTICE Volume: 16 Issue: 3 Pages: 524-525 Published: MAY-JUN 2010
138. MUTATIONS IN GALNT3 GENE: TWO CASES OF TUMORAL CALCINOSIS-HYPERPHOSPHATEMIA
Masi, L.; Franceschelli, F.; Gozzini, A.; et al.
OSTEOPOROSIS INTERNATIONAL Volume: 21 Supplement: 1 Pages: 288-288 Published: MAY 2010
139. CHALLENGES IN ASSESSING COST-EFFECTIVENESS OF THERAPIES FOR DIALYSIS PATIENTS: A CASE STUDY OF SEVELAMER FOR THE TREATMENT OF HYPERPHOSPHATEMIA
Grima, D.; Mendelssohn, D.; Airia, P.; et al.
VALUE IN HEALTH Volume: 13 Issue: 3 Pages: A78-A78 Published: MAY 2010
140. COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN BRAZIL
Rivas, R.; Idrovo, J.; Zapata, L.
VALUE IN HEALTH Volume: 13 Issue: 3 Pages: A210-A210 Published: MAY 2010
141. COST-EFFECTIVENESS OF SEVELAMER IN THE TREATMENT OF HYPERPHOSPHATEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN ARGENTINA
Rivas, R.; Idrovo, J.; Zapata, L.
VALUE IN HEALTH Volume: 13 Issue: 3 Pages: A210-A210 Published: MAY 2010
142. Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
Patent Number: US 07691898
Patent Assignee: Kotobuki Pharmaceutical Co Ltd
Inventor(s): Tomiyama, Hiroshi; Yokota, Masayuki; Tokuzaki, Kazuo; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: APR 6 2010
View Abstract
143. STRATEGIES To IMPROVE PHOSPHORUS CONTROL IN PATIENTS CHRONIC SEVERE HYPERPHOSPHATEMIA
Clark, Barbara; Patel, Ankur; Groves-Seaman, Lori; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 55 Issue: 4 Pages: A49-A49 Meeting Abstract: 71 Published: APR 2010
144. A COST-EFFECTIVENESS MODEL OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
Keith, Michael; Smyth, Michael; Carlton, Rashad; et al.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 55 Issue: 4 Pages: A69-A69 Meeting Abstract: 152 Published: APR 2010
145. Native vitamin D supplementation does not correct vitamin D status in chronic kidney disease patients: possible role of FGF 23 and hyperphosphatemia
Liabeuf, S.; Barreto, D.; Barreto, F.; et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY Volume: 24 Supplement: 1 Pages: 39-39 Meeting Abstract: 188 Published: APR 2010
146. Native vitamin D supplementation does not correct vitamin D status in chronic kidney disease patients : possible role of FGF 23 and hyperphosphatemia
Liabeuf, S.; Barreto, D.; Barreto, F.; et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY Volume: 24 Supplement: 1 Pages: 46-47 Meeting Abstract: 226 Published: APR 2010
147. Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia
Prosdocimo, Domenick A.; Wyler, Steven C.; Romani, Andrea M.; et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY Volume: 298 Issue: 3 Pages: C702-C713 Published: MAR 2010
from Publisher View Abstract
148. Hyperphosphatemia induced by high phosphate-adenine diet progresses nephrotic syndrome in type III Na-dependent phosphate transporter over-expressing rats
Sekiguchi, Sahoko; Shibata, Megumi; Asano, Shougo; et al.
ENDOCRINE JOURNAL Volume: 57 Supplement: 2 Pages: S493-S494 Published: MAR 2010
149. Severe hyperphosphatemia and symptomatic hypocalcemia after bowel cleansing with oral sodium phosphate solution in a patient with postoperative hypoparathyroidism
Berker, Dilek; Isik, Serhat; Aydin, Yusuf; et al.
CENTRAL EUROPEAN JOURNAL OF MEDICINE Volume: 5 Issue: 1 Pages: 65-68 Published: FEB 2010
from Publisher View Abstract
150. Targeting hyperphosphatemia: truth or dare
Meijers, Bjorn; Evenepoel, Pieter
KIDNEY INTERNATIONAL Volume: 77 Issue: 3 Pages: 256-257 Published: FEB 2010
151. Response to 'Targeting hyperphosphatemia: truth or dare'
Isakova, Tamara; Gutierrez, Orlando M.; Wolf, Myles
KIDNEY INTERNATIONAL Volume: 77 Issue: 3 Pages: 257-257 Published: FEB 2010
152. One Year Efficacy and Safety of Lanthanum Carbonate for Hyperphosphatemia in Japanese Chronic Kidney Disease Patients Undergoing Hemodialysis
Shigematsu, Takashi
Group Author(s): Lanthanum Carbonate Res Grp
THERAPEUTIC APHERESIS AND DIALYSIS Volume: 14 Issue: 1 Pages: 12-19 Published: FEB 2010
from Publisher
153. The Control of Hyperphosphatemia in Renal Failure: Between Vascular Calcification and Inflammation
Cozzolino, Mario
BLOOD PURIFICATION Volume: 30 Issue: 3 Pages: 159-160 Published: 2010
154. Hyperphosphatemia after sodium phosphate laxatives in low risk patients: Prospective study
Noemi Casais, Marcela; Rosa-Diez, Guillermo; Perez, Susana; et al.
WORLD JOURNAL OF GASTROENTEROLOGY Volume: 15 Issue: 47 Pages: 5960-5965 Published: DEC 21 2009
from Publisher
155. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model
Nakatani, Teruyo; Ohnishi, Mutsuko; Razzaque, M. Shawkat
FASEB JOURNAL Volume: 23 Issue: 11 Pages: 3702-3711 Published: NOV 2009
from Publisher
156. TREATMENT OPTIONS FOR HYPERPHOSPHATEMIA IN FELINE CKD What's out there?
Kidder, Aimee; Chew, Dennis
JOURNAL OF FELINE MEDICINE AND SURGERY Volume: 11 Issue: 11 Pages: 913-924 Published: NOV 2009
from Publisher
157. Severe Hyperphosphatemia in a Newborn With Renal Insufficiency Because of an Erroneous Medical Prescription
Dissaneewate, Supaporn; Vachvanichsanong, Prayong
JOURNAL OF RENAL NUTRITION Volume: 19 Issue: 6 Pages: 500-502 Published: NOV 2009
from Publisher
158. THE COST-EFFECTIVENESS OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
Keith, M. S.; Carlton, R.; Meissner, B. L.
VALUE IN HEALTH Volume: 12 Issue: 7 Pages: A309-A309 Published: OCT 2009
159. Rare earth metal compositions for treating hyperphosphatemia and related methods
Patent Number: US 07588782
Patent Assignee: Altairnano Inc
Inventor(s): Moerck, Rudi E.; Spitler, Timothy Malcome; Schauer, Edward A.; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: SEP 15 2009
160. Reply to correspondence letter: enema-induced severe hyperphosphatemia in children
Biebl, A.
EUROPEAN JOURNAL OF PEDIATRICS Volume: 168 Issue: 8 Pages: 1021-1021 Published: AUG 2009
161. RE: Enema-induced severe hyperphosphatemia in children
Caswell, Michael
EUROPEAN JOURNAL OF PEDIATRICS Volume: 168 Issue: 8 Pages: 1023-1023 Published: AUG 2009
162. Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
Scaria, P. Thomas; Gangadhar, Reneega; Pisharody, Ramdas
INDIAN JOURNAL OF PHARMACOLOGY Volume: 41 Issue: 4 Pages: 187-191 Published: JUL-AUG 2009
from Publisher
163. Il controllo della fosforemia nell'insufficienza renale cronica.
[Management of hyperphosphatemia in patients with chronic kidney disease].
Savica, V; Santoro, D; Monardo, P; et al.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia Volume: 26 Suppl 46 Pages: 58-61 Published: 2009 Jul-Aug
164. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
Dumitrescu, C. E.; Kelly, M. H.; Khosravi, A.; et al.
OSTEOPOROSIS INTERNATIONAL Volume: 20 Issue: 7 Pages: 1273-1278 Published: JUL 2009
from Publisher
165. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
Michigami, Toshimi
Clinical calcium Volume: 19 Issue: 6 Pages: 785-92 Published: 2009-Jun
from Publisher
166. Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Chiu, Yi-Wen; Teitelbaum, Isaac; Misra, Madhukar; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 4 Issue: 6 Pages: 1089-1096 Published: JUN 2009
from Publisher
167. Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression
Ichikawa, Shoji; Sorenson, Andrea H.; Austin, Anthony M.; et al.
ENDOCRINOLOGY Volume: 150 Issue: 6 Pages: 2543-2550 Published: JUN 2009
from Publisher
168. The Case Metabolic disarray after fire extinguisher powder ingestion The Diagnosis Fire extinguisher powder ingestion with hyperphosphatemia and hypocalcemia
Lin, Cheng-Jui; Chen, Han-Hsiang; Chang, Kuo-Song; et al.
KIDNEY INTERNATIONAL Volume: 75 Issue: 9 Pages: 993-994 Published: MAY 2009
169. Akut hyperfosfataemi hos en dialysepatient efter indgift af fosfatklyx.
[Acute hyperphosphatemia in a dialysis patient after administration of sodium phosphate].
Azad, Brian Behfar Sohrabi; Cordtz, Joakim
Ugeskrift for laeger Volume: 171 Issue: 17 Pages: 1414 Published: 2009-Apr-20
170. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
Roman-Garcia, Pablo; Carrillo-Lopez, Natalia; Cannata-Andia, Jorge B
Journal of renal care Volume: 35 Suppl 1 Pages: 34-8 Published: 2009-Mar
from Publisher
171. Salivary Phosphorus Binding: A Novel Approach to Control Hyperphosphatemia
Eknoyan, Garabed
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 20 Issue: 3 Pages: 460-462 Published: MAR 2009
172. Salivary Phosphate-Binding Chewing Gum Reduces Hyperphosphatemia in Dialysis Patients
Savica, Vincenzo; Calo, Lorenzo A.; Monardo, Paolo; et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 20 Issue: 3 Pages: 639-644 Published: MAR 2009
from Publisher
173. Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial
Sullivan, Catherine; Sayre, Srilekha S.; Leon, Janeen B.; et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Volume: 301 Issue: 6 Pages: 629-635 Published: FEB 11 2009
from Publisher
174. Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome
Gok, Faysal; Chefetz, Ilana; Indelman, Margarita; et al.
ACTA ORTHOPAEDICA Volume: 80 Issue: 1 Pages: 131-134 Article Number: PII 909701055 Published: 2009
from Publisher
175. Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story
Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 53 Issue: 2 Pages: 183-188 Published: FEB 2009
176. [Roles of hyperphosphatemia in vascular calcification].
Shioi, Atsushi; Nishizawa, Yoshiki
Clinical calcium Volume: 19 Issue: 2 Pages: 180-5 Published: 2009-Feb
from Publisher
177. [Management of hyperphosphatemia ; phosphate-binder].
Yokoyama, Keitaro
Clinical calcium Volume: 19 Issue: 2 Pages: 205-12 Published: 2009-Feb
from Publisher
178. [To facilitate the compliance of phosphate binder for the control of hyperphosphatemia in chronic kidney disease patients].
Maruyama, Toru; Kadowaki, Daisuke
Clinical calcium Volume: 19 Issue: 2 Pages: 248-52 Published: 2009-Feb
from Publisher
179. Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients
McIntyre, Christopher W.; Pai, Pearl; Warwick, Graham; et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY Volume: 4 Issue: 2 Pages: 401-409 Published: FEB 2009
from Publisher
180. The control of hyperphosphatemia in chronic kidney disease: Which phosphate binder?
Ketteler, Markus
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Volume: 32 Issue: 2 Pages: 95-100 Published: FEB 2009
181. Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification
Lezaic, V.; Tirmenstajn-Jankovic, B.; Bukvic, D.; et al.
CLINICAL NEPHROLOGY Volume: 71 Issue: 1 Pages: 21-29 Published: JAN 2009
182. Enema-induced severe hyperphosphatemia in children
Biebl, Ariane; Grillenberger, Andrea; Schmitt, Klaus
EUROPEAN JOURNAL OF PEDIATRICS Volume: 168 Issue: 1 Pages: 111-112 Published: JAN 2009
from Publisher
183. Hypercalcemia and hyperphosphatemia secondary to subcutaneous fat necrosis of the newborn - case report
Rorato, Marilia G.; Santos, Maria Zeneide A.; Castro, Luiz Claudio G.; et al.
HORMONE RESEARCH Volume: 72 Pages: 418-418 Published: 2009
184. Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.
Persy, Veerle P; Behets, Geert J; De Broe, Marc E; et al.
International journal of nephrology and renovascular disease Volume: 2 Pages: 1-8 Published: 2009 (Epub 2009 Apr 01)
185. Improvement of Hyperphosphatemia Following Patient Education
Satoh, Minori; Koizumi, Akiko; Izumi, Satoshi; et al.
Journal of Pharmacy Technology Volume: 25 Issue: 1 Pages: 3-9 Published: JAN-FEB 2009
186. Salivary Phosphorus and Phosphate Content of Beverages: Implications for the Treatment of Uremic Hyperphosphatemia
Savica, Vincenzo; Calo, Lorenzo A.; Monardo, Paolo; et al.
JOURNAL OF RENAL NUTRITION Volume: 19 Issue: 1 Pages: 69-72 Published: JAN 2009
from Publisher
187. Fatal latrogenic hyperphosphatemia.
Caswell, Michael
The Journal of the Kentucky Medical Association Volume: 107 Issue: 1 Pages: 28 Published: 2009-Jan
188. Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences
Huybrechts, Krista F.; Caro, J. Jaime; O'Brien, Judith A.
VALUE IN HEALTH Volume: 12 Issue: 1 Pages: 16-19 Published: JAN-FEB 2009
from Publisher
189. Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model
Jiang Ying; Wang Mei
CHINESE MEDICAL JOURNAL Volume: 121 Issue: 23 Pages: 2440-2443 Published: DEC 5 2008
190. The mechanisms of hyperphosphatemia-induced vascular calcification
Cozzolino, M.; Gallieni, M.; Brancaccio, D.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Volume: 31 Issue: 12 Pages: 1002-1003 Published: DEC 2008
191. Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data
Frazao, Joao M.; Adragao, Teresa
KIDNEY INTERNATIONAL Volume: 74 Supplement: 111 Pages: S38-S43 Published: DEC 2008
from Publisher
192. Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients
Ramos, Ana M.; Albalate, Marta; Vazquez, Silvia; et al.
KIDNEY INTERNATIONAL Volume: 74 Supplement: 111 Pages: S88-S93 Published: DEC 2008
from Publisher
193. Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.
Frazao, Joao M; Adragao, Teresa
Kidney international. Supplement Issue: 111 Pages: S38-43 Published: 2008-Dec
from Publisher
194. Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients.
Ramos, Ana M; Albalate, Marta; Vazquez, Silvia; et al.
Kidney international. Supplement Issue: 111 Pages: S88-93 Published: 2008-Dec
from Publisher
195. Hyperphosphatemia in renal failure.
Robb, Meigan
RN Volume: 71 Issue: 12 Pages: 26-30; quiz 31 Published: 2008-Dec
196. HYPERPHOSPHATEMIA IN THE CALCIUM ACETATE RENAGEL EVALUATION-2 (CARE-2) STUDY
Bleyer, Anthony J.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 52 Issue: 5 Pages: 1024-1024 Published: NOV 2008
197. IN REPLY TO 'HYPERPHOSPHATEMIA IN THE CALCIUM ACETATE RENAGEL EVALUATION-2 (CARE-2) STUDY' AND 'BINDER WARS'
Qunibi, Wajeh; Muenz, Larry R.; Diaz-Buxo, Jose A.
AMERICAN JOURNAL OF KIDNEY DISEASES Volume: 52 Issue: 5 Pages: 1025-1025 Published: NOV 2008
198. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia
Shigematsu, T.
Group Author(s): Lanthanum Carbonate Grp
CLINICAL NEPHROLOGY Volume: 70 Issue: 5 Pages: 404-410 Published: NOV 2008
199. Lanthanum Carbonate Treatment of Patients with Hyperphosphatemia Undergoing CAPD
Kawanishi, H.; Ishida, M.; Ishizaki, M.; et al.
Group Author(s): Lanthanum Carbonate Study Grp Japa
PERITONEAL DIALYSIS INTERNATIONAL Volume: 28 Issue: 6 Pages: 673-675 Published: NOV-DEC 2008
200. Management of Hyperphosphatemia Is an Important Novel Therapeutic Target In Chronic Heart Failure
Asanuma, Hiroshi; Asakura, Masanori; Kim, Jiyoong; et al.
CIRCULATION Volume: 118 Issue: 18 Pages: S433-S434 Published: OCT 28 2008
No comments:
Post a Comment
Your comment will appear after it is approved